EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+0.43%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.29B
AUM Growth
+$3.29B
(-3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
70.15%
Holding
84
New
9
Increased
10
Reduced
4
Closed
18
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$63.3M |
| 2 |
Zymeworks
ZYME
|
$59.5M |
| 3 |
Adicet Bio
ACET
|
$31.8M |
| 4 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
$29.6M |
| 5 |
Dyne Therapeutics
DYN
|
$26.9M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$70.9M |
| 2 |
Gossamer Bio
GOSS
|
$49.8M |
| 3 |
Avidity Biosciences
RNA
|
$47.3M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$39.1M |
| 5 |
Design Therapeutics
DSGN
|
$16.8M |
Sector Composition
| 1 | Healthcare | 99.78% |
| 2 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crinetics Pharmaceuticals
CRNX
$3.26B
| $24.3M | 0.74% |
1,330,263
| – | – |
|
27
Oric Pharmaceuticals
ORIC
$1.03B
| $20.1M | 0.61% |
3,418,068
| – | – |
|
28
Kymera Therapeutics
KYMR
$3.1B
| $19.9M | 0.6% |
796,093
| – | – |
|
|
LENZ
29
LENZ Therapeutics
LENZ
$1.12B
| $19M | 0.58% |
5,712,096
+4,129,961
| +261% | +$13.7M |
|
30
Janux Therapeutics
JANX
$1.38B
| $18.7M | 0.57% |
1,421,319
| – | – |
|
|
KDNY
31
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $18.1M | 0.55% |
690,000
| – | – |
|
|
CNTA
32
Centessa Pharmaceuticals
CNTA
$2.13B
| $16.2M | 0.49% |
5,232,279
+1,995,927
| +62% | +$6.19M |
|
|
PSTX
33
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $14M | 0.43% |
2,650,000
| – | – |
|
34
Ventyx Biosciences
VTYX
$184M
| $13.1M | 0.4% |
400,000
| – | – |
|
35
Ovid Therapeutics
OVID
$94.6M
| $11.4M | 0.35% |
6,117,400
| – | – |
|
36
Prime Medicine
PRME
$595M
| $11.1M | 0.34% |
+600,000
| New | +$11.1M |
|
37
Cullinan Oncology
CGEM
$456M
| $10.9M | 0.33% |
1,035,038
-108,180
| -9% | -$1.14M |
|
|
TSVT
38
DELISTED
2seventy bio
TSVT
| $10.7M | 0.33% |
1,143,494
-1,197,819
| -51% | -$11.2M |
|
39
Geron
GERN
$893M
| $9.75M | 0.3% |
4,028,507
+1,726,527
| +75% | +$4.18M |
|
|
AVEO
40
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $9.72M | 0.3% |
650,489
| – | – |
|
41
BioAtla
BCAB
$28.7M
| $9.28M | 0.28% |
+1,124,439
| New | +$9.28M |
|
|
42
Design Therapeutics
DSGN
$339M
| $9.08M | 0.28% |
884,903
-1,634,365
| -65% | -$16.8M |
|
|
GRCL
43
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $7.69M | 0.23% |
3,343,202
+1,421,892
| +74% | +$3.27M |
|
44
MacroGenics
MGNX
$121M
| $7.5M | 0.23% |
1,117,455
+186,500
| +20% | +$1.25M |
|
45
Immatics
IMTX
$662M
| $6.47M | 0.2% |
+743,000
| New | +$6.47M |
|
46
Arcutis Biotherapeutics
ARQT
$1.91B
| $6.15M | 0.19% |
415,322
| – | – |
|
47
Precision BioSciences
DTIL
$59.5M
| $5.99M | 0.18% |
5,035,971
| – | – |
|
48
Orchestra BioMed
OBIO
$147M
| $3.99M | 0.12% |
400,000
| – | – |
|
49
Cartesian Therapeutics
RNAC
$267M
| $3.96M | 0.12% |
3,500,000
| – | – |
|
50
Praxis Precision Medicines
PRAX
$980M
| $3.77M | 0.11% |
1,585,324
+89,000
| +6% | +$212K |
|